Phase 3 data show intismeran plus pembrolizumab reduced recurrence or death risk by 42% in patients with resected stage IIB-IV melanoma.
Poll|Articles|October 9, 2023
POLL: How Often Do You Collaborate With Gynecologists Regarding Genital Skin Cancers?
Author(s)Dermatology Times Staff
Listen
0:00 / 0:00
Key Takeaways
- Lichen sclerosus is associated with genital skin cancers, including vulvar and penile SCCs and genital melanomas.
- Approximately 4% of patients with lichen sclerosus may develop vulvar cancer.
Click here to answer this week's skin cancer poll.
Advertisement
How often do you collaborate with gynecologists regarding genital skin cancers?
The October issue of Dermatology Times recently reviewed in-depth the
- Lichen sclerosus, a noncancerous dermatologic condition, has been linked to genital skin cancers such as vulvar and penile squamous cell carcinomas (SCCs), as well as genital melanomas. About 4% of patients with lichen sclerosus may develop vulvar cancer.
- Genital cancers, including vaginal melanomas, vulvar melanoma, and penile melanoma, are relatively rare but can be associated with feelings of shame, stigma, and discomfort. It is crucial for clinicians to encourage patients to report unusual signs and symptoms to facilitate early diagnosis and treatment.
Due to the quality-of-life impacts of genital skin cancers, it can be beneficial for dermatologists and gynecologists to collaborate together when necessary to optimize patient care and outcomes.
What are your experiences with treating genital skin cancers or lichen sclerosus? Email us at
Advertisement
Related to this article
Shannon Trotter, DO, moderated a Dermatology Times Case-Based Roundtable event on how pharmacokinetics, adverse event timing, and trial response criteria should shape hedgehog pathway inhibitor selection in advanced BCC.
Two-year oral IL-23 data, GLP-1 biomarker findings, and a nonsurgical option for superficial basal cell carcinoma headline the sessions covered in Las Vegas.
Prospective data suggest DecisionDx-Melanoma may help refine SLNB decisions and identify recurrence risk beyond conventional staging.
Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.
Dermatology Times is looking back on the top stories in dermatology from the month of October.
From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology trends from October.
Dermatology PAs unpack 4 frightening skin care myths and trends, from sunscreen misinformation and citrus DIYs to overusing actives and beef tallow.
Advertisement
Advertisement